I would suggest some posters here read about Celgene's Aprilimast and its success in phase 3. It will soon capture the psoriasis market and will be a global success. Why would Leo want to take on Celgene and it's product when he can rapidly progress Brilacidin with the limited funds they have on hand.
Market Data 
Markets 
AI
